Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 23, 2026 2.625
October 22, 2026 2.671
October 21, 2026 2.627
October 20, 2026 2.633
October 19, 2026 2.55
October 16, 2026 2.578
October 15, 2026 2.597
October 14, 2026 2.538
October 13, 2026 2.456
October 12, 2026 2.487
October 09, 2026 2.434
October 08, 2026 2.412
October 07, 2026 2.420
October 06, 2026 2.409
October 05, 2026 2.369
October 02, 2026 2.397
October 01, 2026 2.396
September 30, 2026 2.472
September 29, 2026 2.447
September 28, 2026 2.453
September 25, 2026 2.570
September 24, 2026 2.596
September 23, 2026 2.614
September 22, 2026 2.621
September 21, 2026 2.603
Date Value
September 18, 2026 2.559
September 17, 2026 2.574
September 16, 2026 2.526
September 15, 2026 2.524
September 14, 2026 2.588
September 11, 2026 2.548
September 10, 2026 2.586
September 09, 2026 2.634
September 08, 2026 2.642
September 04, 2026 2.699
September 03, 2026 2.750
September 02, 2026 2.778
September 01, 2026 2.686
August 31, 2026 2.606
August 28, 2026 2.590
August 27, 2026 2.634
August 26, 2026 2.657
August 25, 2026 2.718
August 24, 2026 2.702
August 21, 2026 2.720
August 20, 2026 2.695
August 19, 2026 2.742
August 18, 2026 2.642
August 17, 2026 2.628
August 14, 2026 2.620

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Amgen, Inc. 20.32
AbbVie, Inc. --
Biogen, Inc. 1.964
Incyte Corp. 3.665
Vertex Pharmaceuticals, Inc. 6.556

Price to Book Value Related Metrics